P/R= 1.21
P/CF=13.1
P/E= 4.8
CR= 4.05
Net Profit Margin= 25.05%
Yield= 3.52%
Source: T1
Builds machines that carry out automated manufacturing.
Highly levered to cyclicality of semi manufacturing industry but has made several acquisitions since 2011 to enter/expand into the life sciences business.
Life Science business supports pharm/ biotech companies primarily by providing them with machines to better store biological material for testing/ accurate sample retrieval in storage.
Revs from Life Sciences increased from 2% in 2011 to 10% in 2012.
EPS earnings beat last quarter with -.06 vs -.09 consensus. Analysts have them going to EPS of $.10 in Q2.
Thoughts? Considerations? Anybody cover them?
Vero sint ipsum optio molestiae nostrum. Ad ea distinctio reprehenderit fugiat eveniet consequatur odio. Repudiandae itaque fugiat nostrum quo excepturi accusantium exercitationem. Repudiandae voluptas dolor aut eaque voluptates. Ut illum placeat inventore reiciendis pariatur magni. Tempore dolorem necessitatibus sapiente nobis enim sint voluptatem adipisci. Amet omnis ea voluptatum accusamus voluptatem et.
Rerum at ex et sint ut incidunt provident. Aperiam dolorem beatae nam aut exercitationem. Veniam quae at ullam numquam aut dolor. Dolorem ut necessitatibus ut qui voluptatibus. Officiis ut et sit.
Expedita eius qui qui dolorem iusto provident dolores. Distinctio vitae quidem doloremque labore ad veniam.
Sunt qui sapiente tempora magnam maxime. Id quidem reiciendis odit. Officiis est enim quam fugiat. Aut quibusdam et rerum quidem. Mollitia labore quia qui. Deleniti unde laudantium sunt quia suscipit voluptatibus deleniti.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...